Clinical trials in Prestice

Influenza

Not recruiting

Registered drugNo placebo

Study on the Effectiveness of an MF59-Adjuvanted Influenza Vaccine Compared to a Non-Adjuvanted Vaccine in Adults Aged 65 and Older

Registered drugNo placebo

Czechia

Participants:65+ years · Healthy volunteers
Substances:A/DARWIN/9/2021 (H3N2) - LIKE STRAIN (A/DARWIN/6/2021, IVR-227)
Sponsor:Seqirus UK Limited

Contact Research Centre

Other cities in Czechia

The busiest research cities in the country

All 158 cities in Czechia

A/DARWIN/9/2021 (H3N2) - LIKE STRAIN (A/DARWIN/6/2021, IVR-227) 1 A/Victoria/4897/2022 (H1N1)Pdm09-Like Strain (A/Victoria/4897/2022, Ivr-238) 1 B/Phuket/3073/2013-Like Virus (B/Phuket/3073/2013, Wild Type) 1 Influenza A/Victoria/4897/2022 Ivr-238 (H1N1), Inactivated 1 Influenza Virus A/Thailand/8/2022 (H3N2) Ivr-237-Like Strain (A/Thailand/8/2022) 1 Influenza Virus B/Austria/1359417/2021-Like Strain (B/Austria/1359417/2021, Bvr-26) 1

Clinical research in Prestice

What the registry says about research in the country

01 Infectious Disease Research

Research focusing on influenza prevention in older adults, evaluating enhanced vaccine formulations for improved immune response.

Vaccine Development
Elderly Population Studies
Infectious Disease Prevention

Comparative analysis of adjuvanted and non-adjuvanted influenza vaccines, specifically designed to protect individuals aged 65 and above from seasonal influenza strains.

02 Immunology Studies

Investigation of immune system responses to different vaccine formulations, with particular attention to efficacy in senior populations.

Vaccine Immunogenicity
Age-Related Immunity
Preventive Medicine

Research examining the effectiveness of specialized vaccine adjuvants in enhancing immune protection against both influenza A and B strains.

03 Geriatric Medicine

Clinical evaluation of preventive treatments specifically tailored for older adults' health needs and immune system characteristics.

Senior Healthcare
Preventive Care
Vaccine Safety

Assessment of vaccine safety profiles and protective benefits in the elderly population, focusing on real-world effectiveness.

Clinical trials in Prestice

1 trial in Prestice

Influenza

Study on the Effectiveness of an MF59-Adjuvanted Influenza Vaccine Compared to a Non-Adjuvanted Vaccine in Adults Aged 65 and Older

Filter the trials

Other cities in Czechia

Clinical research in Prestice

Prefer not to search? Our Concierge searches the trials for you.

Clinical trials in Prestice

1 trial in Prestice

Influenza

Study on the Effectiveness of an MF59-Adjuvanted Influenza Vaccine Compared to a Non-Adjuvanted Vaccine in Adults Aged 65 and Older

Other cities in Czechia

Related

Clinical research in Prestice

Prefer not to search? Our Concierge searches the trials for you.